SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'TAU'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	ALA A 69 SER A 70 LYS A 73 SER A 251 ASN A 253 LYS A 357 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.30A	1ghmA-3v39A: 17.7	1ghmA-3v39A: 23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	8 / 12	ALA A 69 SER A 70 LYS A 73 SER A 251 ASN A 253 THR A 342 LYS A 357 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.35A	1i2wA-3v39A: 17.9	1i2wA-3v39A: 22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	ALA A 69 SER A 70 LYS A 73 SER A 251 ASN A 253 THR A 342 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) None TAU A 501 (-3.5A)	0.34A	1i2wB-3v39A: 18.0	1i2wB-3v39A: 22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JR1_B_MOAB1333_1 (INOSINE-5'-MONOPHOSP HATE DEHYDROGENASE 2)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	4 / 8	SER A 251 ASN A 252 GLY A 158 GLY A 291	TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None	0.86A	1jr1B-3v39A: undetectable	1jr1B-3v39A: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MEH_A_MOAA600_1 (INOSINE-5'-MONOPHOSP HATE DEHYDROGENASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 10	SER A 251 ASN A 252 ILE A 157 GLY A 158 GLY A 291	TAU A 501 (-2.6A) None None TAU A 501 ( 4.3A) None	1.18A	1mehA-3v39A: undetectable	1mehA-3v39A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1N4F_A_ASRA141_0 (LYSOZYME C)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	4 / 6	ASN A 292 GLY A 159 THR A 161 PRO A 162	TAU A 501 (-3.7A) None None None	0.85A	1n4fA-3v39A: undetectable	1n4fA-3v39A: 15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	SER A 70 LYS A 73 SER A 251 ASN A 253 THR A 342 LYS A 357 GLY A 359	TAU A 501 (-1.5A) TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.29A	1ymxA-3v39A: 17.5	1ymxA-3v39A: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 LYS A 73 SER A 251 ASN A 253 LYS A 357 GLY A 359	TAU A 501 (-1.5A) TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.27A	1ymxB-3v39A: 17.4	1ymxB-3v39A: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y03_A_5FWA601_1 (BETA-1 ADRENERGIC RECEPTOR)	1gy9	ALPHA-KETOGLUTARATE- DEPENDENT TAURINE DIOXYGENASE (Escherichia coli)	5 / 12	TRP A 248 ASP A 101 VAL A 102 PHE A 159 ASN A 95	None FE A 300 (-2.3A) TAU A 350 (-3.8A) TAU A 350 (-4.3A) AKG A 351 ( 3.5A)	1.08A	2y03A-1gy9A: undetectable	2y03A-1gy9A: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y04_A_68HA601_1 (BETA-1 ADRENERGIC RECEPTOR)	1gy9	ALPHA-KETOGLUTARATE- DEPENDENT TAURINE DIOXYGENASE (Escherichia coli)	5 / 11	TRP A 248 ASP A 101 VAL A 102 PHE A 159 ASN A 95	None FE A 300 (-2.3A) TAU A 350 (-3.8A) TAU A 350 (-4.3A) AKG A 351 ( 3.5A)	1.08A	2y04A-1gy9A: undetectable	2y04A-1gy9A: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D4S_A_TIMA401_1 (BETA-2 ADRENERGIC RECEPTOR/T4-LYSOZYME CHIMERA)	1gy9	ALPHA-KETOGLUTARATE- DEPENDENT TAURINE DIOXYGENASE (Escherichia coli)	5 / 12	TRP A 248 ASP A 101 VAL A 102 PHE A 159 ASN A 95	None FE A 300 (-2.3A) TAU A 350 (-3.8A) TAU A 350 (-4.3A) AKG A 351 ( 3.5A)	1.17A	3d4sA-1gy9A: undetectable	3d4sA-1gy9A: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	LYS A 73 SER A 251 ASN A 253 THR A 342 LYS A 357 GLY A 359	TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.37A	3hlwA-3v39A: 17.5	3hlwA-3v39A: 20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 251 ASN A 253 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-2.6A) TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.28A	3hlwB-3v39A: 17.5	3hlwB-3v39A: 20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	LYS A 73 ASN A 253 LYS A 357 THR A 358 GLY A 359	TAU A 501 ( 3.7A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.33A	3huoA-3v39A: 17.5	3huoA-3v39A: 20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	ALA A 69 SER A 70 LYS A 73 ASN A 253 THR A 358 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 ( 3.7A) TAU A 501 (-3.1A) None TAU A 501 (-3.5A)	0.36A	3mzeA-3v39A: 7.8	3mzeA-3v39A: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 ILE A 157 SER A 251 THR A 342 LYS A 357 THR A 358	TAU A 501 (-1.5A) None TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None	1.25A	3ny4A-3v39A: 16.5	3ny4A-3v39A: 22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.50A	3ny4A-3v39A: 16.5	3ny4A-3v39A: 22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	LYS A 73 SER A 251 ASN A 253 LYS A 357 GLY A 359 SER A 360	TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) TAU A 501 (-3.5A) None	0.50A	3q07A-3v39A: 17.4	3q07A-3v39A: 20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	LYS A 73 SER A 251 ASN A 253 LYS A 357 GLY A 359	TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.33A	3q07B-3v39A: 17.7	3q07B-3v39A: 20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SFU_C_RBVC601_1 (RNA POLYMERASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 11	ARG A 246 LEU A 115 THR A 161 ASN A 253 GLY A 158	PGE A 505 (-3.2A) None None TAU A 501 (-3.1A) TAU A 501 ( 4.3A)	1.12A	3sfuC-3v39A: undetectable	3sfuC-3v39A: 22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	ALA A 69 SER A 70 SER A 251 ASN A 253 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.33A	3sh8A-3v39A: 17.9	3sh8A-3v39A: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	ALA A 69 SER A 70 LYS A 73 SER A 251 ASN A 253 LYS A 357 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.45A	3sh8B-3v39A: 18.0	3sh8B-3v39A: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWR_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 11	ALA A 69 PHE A 286 ASN A 303 GLY A 359 ILE A 71	TAU A 501 (-3.4A) None None TAU A 501 (-3.5A) None	1.44A	3vwrA-3v39A: 12.5	3vwrA-3v39A: 19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AMJ_A_CVDA1359_1 (BETA-1 ADRENERGIC RECEPTOR)	1gy9	ALPHA-KETOGLUTARATE- DEPENDENT TAURINE DIOXYGENASE (Escherichia coli)	5 / 12	TRP A 248 ASP A 101 VAL A 102 PHE A 159 ASN A 95	None FE A 300 (-2.3A) TAU A 350 (-3.8A) TAU A 350 (-4.3A) AKG A 351 ( 3.5A)	1.03A	4amjA-1gy9A: undetectable	4amjA-1gy9A: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	LYS A 73 SER A 251 ASN A 253 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.37A	4euzA-3v39A: 16.8	4euzA-3v39A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 10	SER A 251 ASN A 253 LYS A 357 THR A 358 GLY A 359 ALA A 69	TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A) TAU A 501 (-3.4A)	1.42A	4fh2A-3v39A: 18.5	4fh2A-3v39A: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	ALA A 69 SER A 70 SER A 251 ASN A 253 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.32A	4n9kA-3v39A: 18.1	4n9kA-3v39A: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	ALA A 69 SER A 70 SER A 251 ASN A 253 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.35A	4n9kB-3v39A: 18.1	4n9kB-3v39A: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	ASN A 253 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.31A	4pm5A-3v39A: 17.7	4pm5A-3v39A: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	LYS A 73 ASN A 253 THR A 342 LYS A 357 GLY A 359	TAU A 501 ( 3.7A) TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.42A	4pm7A-3v39A: 17.8	4pm7A-3v39A: 22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	LYS A 73 SER A 251 ASN A 253 LYS A 357 GLY A 359	TAU A 501 ( 3.7A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.72A	4pm7A-3v39A: 17.8	4pm7A-3v39A: 22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	ASN A 253 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.34A	4pm9A-3v39A: 17.6	4pm9A-3v39A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 251 ASN A 253 LYS A 357 THR A 358 GLY A 359 ALA A 69	TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A) TAU A 501 (-3.4A)	1.47A	4pm9A-3v39A: 17.6	4pm9A-3v39A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	ALA A 69 SER A 70 SER A 251 ASN A 253 LYS A 357 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.34A	5ghyA-3v39A: 17.9	5ghyA-3v39A: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	ALA A 69 SER A 70 SER A 251 ASN A 253 LYS A 357 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.33A	5ghyB-3v39A: 17.9	5ghyB-3v39A: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 11	ALA A 69 SER A 70 SER A 251 ASN A 253 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.34A	5ghzA-3v39A: 18.0	5ghzA-3v39A: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 10	ALA A 69 SER A 70 SER A 251 ASN A 253 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-3.4A) TAU A 501 (-1.5A) TAU A 501 (-2.6A) TAU A 501 (-3.1A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.32A	5ghzB-3v39A: 18.1	5ghzB-3v39A: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.40A	6b5yB-3v39A: 17.0	6b5yB-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.45A	6b5yD-3v39A: 17.0	6b5yD-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.25A	6b68B-3v39A: 17.0	6b68B-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.29A	6b68D-3v39A: 17.0	6b68D-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.29A	6b69A-3v39A: 17.0 6b69B-3v39A: 16.8	6b69A-3v39A: 11.89 6b69B-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.29A	6b69D-3v39A: 16.8	6b69D-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.29A	6b6aB-3v39A: 16.9	6b6aB-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 ILE A 157 SER A 251 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) None TAU A 501 (-2.6A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	1.10A	6b6aD-3v39A: 16.9	6b6aD-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	SER A 70 SER A 251 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.33A	6b6cA-3v39A: 16.9	6b6cA-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	0.65A	6b6dA-3v39A: 16.8	6b6dA-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	7 / 12	SER A 70 ILE A 157 SER A 251 THR A 342 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) None TAU A 501 (-2.6A) None TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	1.28A	6b6eA-3v39A: 16.8	6b6eA-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	6 / 12	SER A 70 ILE A 157 SER A 251 LYS A 357 THR A 358 GLY A 359	TAU A 501 (-1.5A) None TAU A 501 (-2.6A) TAU A 501 ( 4.3A) None TAU A 501 (-3.5A)	1.26A	6b6fA-3v39A: 16.7	6b6fA-3v39A: 11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	3v39	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Bdellovibrio bacteriovorus)	5 / 12	SER A 251 ASN A 253 THR A 342 LYS A 357 GLY A 359	TAU A 501 (-2.6A) TAU A 501 (-3.1A) None TAU A 501 ( 4.3A) TAU A 501 (-3.5A)	0.27A	6c79A-3v39A: 17.5	6c79A-3v39A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DCH_A_ACTA401_0 (SCOE PROTEIN)	1gy9	ALPHA-KETOGLUTARATE- DEPENDENT TAURINE DIOXYGENASE (Escherichia coli)	4 / 5	HIS A 99 ASP A 101 HIS A 255 ARG A 270	FE A 300 (-3.4A) FE A 300 (-2.3A) FE A 300 ( 3.3A) TAU A 350 ( 2.9A)	0.37A	6dchA-1gy9A: 29.7	6dchA-1gy9A: 27.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7J_A_5FWA401_0 (BETA-1 ADRENERGIC RECEPTOR)	1gy9	ALPHA-KETOGLUTARATE- DEPENDENT TAURINE DIOXYGENASE (Escherichia coli)	5 / 12	TRP A 248 ASP A 101 VAL A 102 PHE A 159 ASN A 95	None FE A 300 (-2.3A) TAU A 350 (-3.8A) TAU A 350 (-4.3A) AKG A 351 ( 3.5A)	1.22A	6h7jA-1gy9A: undetectable	6h7jA-1gy9A: 17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7M_A_68HA504_0 (BETA-1 ADRENERGIC RECEPTOR)	1gy9	ALPHA-KETOGLUTARATE- DEPENDENT TAURINE DIOXYGENASE (Escherichia coli)	5 / 12	TRP A 248 ASP A 101 VAL A 102 PHE A 159 ASN A 95	None FE A 300 (-2.3A) TAU A 350 (-3.8A) TAU A 350 (-4.3A) AKG A 351 ( 3.5A)	1.20A	6h7mA-1gy9A: undetectable	6h7mA-1gy9A: 17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7M_B_68HB405_0 (BETA-1 ADRENERGIC RECEPTOR)	1gy9	ALPHA-KETOGLUTARATE- DEPENDENT TAURINE DIOXYGENASE (Escherichia coli)	5 / 12	TRP A 248 ASP A 101 VAL A 102 PHE A 159 ASN A 95	None FE A 300 (-2.3A) TAU A 350 (-3.8A) TAU A 350 (-4.3A) AKG A 351 ( 3.5A)	1.20A	6h7mB-1gy9A: undetectable	6h7mB-1gy9A: 17.21

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"ALA A  69;SER A  70;LYS A  73;SER A 251;ASN A 253;LYS A 357;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.30A","1ghmA-3v39A:17.7",null],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",8,"ALA A  69;SER A  70;LYS A  73;SER A 251;ASN A 253;THR A 342;LYS A 357;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.35A","1i2wA-3v39A:17.9","1ghmA-3v39A:23.00"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"ALA A  69;SER A  70;LYS A  73;SER A 251;ASN A 253;THR A 342;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);None;TAU A 501 (-3.5A)","0.34A","1i2wB-3v39A:18.0","1i2wA-3v39A:22.66"],["1JR1_B_MOAB1333_1","INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE 2","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",4,"SER A 251;ASN A 252;GLY A 158;GLY A 291","TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None","0.86A","1jr1B-3v39A:undetectable","1i2wB-3v39A:22.66"],["1MEH_A_MOAA600_1","INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"SER A 251;ASN A 252;ILE A 157;GLY A 158;GLY A 291","TAU A 501 (-2.6A);None;None;TAU A 501 ( 4.3A);None","1.18A","1mehA-3v39A:undetectable","1jr1B-3v39A:22.24"],["1N4F_A_ASRA141_0","LYSOZYME C","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",4,"ASN A 292;GLY A 159;THR A 161;PRO A 162","TAU A 501 (-3.7A);None;None;None","0.85A","1n4fA-3v39A:undetectable","1mehA-3v39A:22.65"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"SER A  70;LYS A  73;SER A 251;ASN A 253;THR A 342;LYS A 357;GLY A 359","TAU A 501 (-1.5A);TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.29A","1ymxA-3v39A:17.5","1n4fA-3v39A:15.61"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;LYS A  73;SER A 251;ASN A 253;LYS A 357;GLY A 359","TAU A 501 (-1.5A);TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.27A","1ymxB-3v39A:17.4","1ymxA-3v39A:20.72"],["2Y03_A_5FWA601_1","BETA-1 ADRENERGIC RECEPTOR","1gy9","ALPHA-KETOGLUTARATE-DEPENDENT TAURINE DIOXYGENASE","Escherichia coli",5,"TRP A 248;ASP A 101;VAL A 102;PHE A 159;ASN A  95","None; FE A 300 (-2.3A);TAU A 350 (-3.8A);TAU A 350 (-4.3A);AKG A 351 ( 3.5A)","1.08A","2y03A-1gy9A:undetectable","1ymxB-3v39A:20.72"],["2Y04_A_68HA601_1","BETA-1 ADRENERGIC RECEPTOR","1gy9","ALPHA-KETOGLUTARATE-DEPENDENT TAURINE DIOXYGENASE","Escherichia coli",5,"TRP A 248;ASP A 101;VAL A 102;PHE A 159;ASN A  95","None; FE A 300 (-2.3A);TAU A 350 (-3.8A);TAU A 350 (-4.3A);AKG A 351 ( 3.5A)","1.08A","2y04A-1gy9A:undetectable","2y03A-1gy9A:20.77"],["3D4S_A_TIMA401_1","BETA-2 ADRENERGIC RECEPTOR\/T4-LYSOZYME CHIMERA","1gy9","ALPHA-KETOGLUTARATE-DEPENDENT TAURINE DIOXYGENASE","Escherichia coli",5,"TRP A 248;ASP A 101;VAL A 102;PHE A 159;ASN A  95","None; FE A 300 (-2.3A);TAU A 350 (-3.8A);TAU A 350 (-4.3A);AKG A 351 ( 3.5A)","1.17A","3d4sA-1gy9A:undetectable","2y04A-1gy9A:20.77"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"LYS A  73;SER A 251;ASN A 253;THR A 342;LYS A 357;GLY A 359","TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.37A","3hlwA-3v39A:17.5","3d4sA-1gy9A:18.99"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A 251;ASN A 253;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-2.6A);TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.28A","3hlwB-3v39A:17.5","3hlwA-3v39A:20.96"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"LYS A  73;ASN A 253;LYS A 357;THR A 358;GLY A 359","TAU A 501 ( 3.7A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.33A","3huoA-3v39A:17.5","3hlwB-3v39A:20.96"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"ALA A  69;SER A  70;LYS A  73;ASN A 253;THR A 358;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 ( 3.7A);TAU A 501 (-3.1A);None;TAU A 501 (-3.5A)","0.36A","3mzeA-3v39A:7.8","3huoA-3v39A:20.96"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;ILE A 157;SER A 251;THR A 342;LYS A 357;THR A 358","TAU A 501 (-1.5A);None;TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None","1.25A","3ny4A-3v39A:16.5","3mzeA-3v39A:22.80"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.50A","3ny4A-3v39A:16.5","3ny4A-3v39A:22.42"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"LYS A  73;SER A 251;ASN A 253;LYS A 357;GLY A 359;SER A 360","TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);TAU A 501 (-3.5A);None","0.50A","3q07A-3v39A:17.4","3ny4A-3v39A:22.42"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"LYS A  73;SER A 251;ASN A 253;LYS A 357;GLY A 359","TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.33A","3q07B-3v39A:17.7","3q07A-3v39A:20.96"],["3SFU_C_RBVC601_1","RNA POLYMERASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"ARG A 246;LEU A 115;THR A 161;ASN A 253;GLY A 158","PGE A 505 (-3.2A);None;None;TAU A 501 (-3.1A);TAU A 501 ( 4.3A)","1.12A","3sfuC-3v39A:undetectable","3q07B-3v39A:20.96"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"ALA A  69;SER A  70;SER A 251;ASN A 253;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.33A","3sh8A-3v39A:17.9","3sfuC-3v39A:22.05"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"ALA A  69;SER A  70;LYS A  73;SER A 251;ASN A 253;LYS A 357;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.45A","3sh8B-3v39A:18.0","3sh8A-3v39A:22.67"],["3VWR_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"ALA A  69;PHE A 286;ASN A 303;GLY A 359;ILE A  71","TAU A 501 (-3.4A);None;None;TAU A 501 (-3.5A);None","1.44A","3vwrA-3v39A:12.5","3sh8B-3v39A:22.67"],["4AMJ_A_CVDA1359_1","BETA-1 ADRENERGIC RECEPTOR","1gy9","ALPHA-KETOGLUTARATE-DEPENDENT TAURINE DIOXYGENASE","Escherichia coli",5,"TRP A 248;ASP A 101;VAL A 102;PHE A 159;ASN A  95","None; FE A 300 (-2.3A);TAU A 350 (-3.8A);TAU A 350 (-4.3A);AKG A 351 ( 3.5A)","1.03A","4amjA-1gy9A:undetectable","3vwrA-3v39A:19.47"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"LYS A  73;SER A 251;ASN A 253;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.37A","4euzA-3v39A:16.8","4amjA-1gy9A:20.77"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A 251;ASN A 253;LYS A 357;THR A 358;GLY A 359;ALA A  69","TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A);TAU A 501 (-3.4A)","1.42A","4fh2A-3v39A:18.5","4euzA-3v39A:22.65"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"ALA A  69;SER A  70;SER A 251;ASN A 253;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.32A","4n9kA-3v39A:18.1","4fh2A-3v39A:19.53"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"ALA A  69;SER A  70;SER A 251;ASN A 253;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.35A","4n9kB-3v39A:18.1","4n9kA-3v39A:22.67"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"ASN A 253;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.31A","4pm5A-3v39A:17.7","4n9kB-3v39A:22.67"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"LYS A  73;ASN A 253;THR A 342;LYS A 357;GLY A 359","TAU A 501 ( 3.7A);TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.42A","4pm7A-3v39A:17.8","4pm5A-3v39A:20.72"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"LYS A  73;SER A 251;ASN A 253;LYS A 357;GLY A 359","TAU A 501 ( 3.7A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.72A","4pm7A-3v39A:17.8","4pm7A-3v39A:22.28"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"ASN A 253;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.34A","4pm9A-3v39A:17.6","4pm7A-3v39A:22.28"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A 251;ASN A 253;LYS A 357;THR A 358;GLY A 359;ALA A  69","TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A);TAU A 501 (-3.4A)","1.47A","4pm9A-3v39A:17.6","4pm9A-3v39A:22.03"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"ALA A  69;SER A  70;SER A 251;ASN A 253;LYS A 357;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.34A","5ghyA-3v39A:17.9","4pm9A-3v39A:22.03"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"ALA A  69;SER A  70;SER A 251;ASN A 253;LYS A 357;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.33A","5ghyB-3v39A:17.9","5ghyA-3v39A:22.67"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"ALA A  69;SER A  70;SER A 251;ASN A 253;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.34A","5ghzA-3v39A:18.0","5ghyB-3v39A:22.67"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"ALA A  69;SER A  70;SER A 251;ASN A 253;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-3.4A);TAU A 501 (-1.5A);TAU A 501 (-2.6A);TAU A 501 (-3.1A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.32A","5ghzB-3v39A:18.1","5ghzA-3v39A:22.67"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.40A","6b5yB-3v39A:17.0","5ghzB-3v39A:22.67"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.45A","6b5yD-3v39A:17.0","6b5yB-3v39A:11.89"],["6B68_B_9F2B301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.25A","6b68B-3v39A:17.0","6b5yD-3v39A:11.89"],["6B68_D_9F2D400_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"SER A  70;SER A 251;THR A 342;LYS A 357;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.29A","6b68D-3v39A:17.0","6b68B-3v39A:11.89"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.29A","6b69A-3v39A:17.0;6b69B-3v39A:16.8","6b68D-3v39A:11.89"],["6B69_D_9F2D301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.29A","6b69D-3v39A:16.8","6b69A-3v39A:11.89;6b69B-3v39A:11.89"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.29A","6b6aB-3v39A:16.9","6b69D-3v39A:11.89"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;ILE A 157;SER A 251;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);None;TAU A 501 (-2.6A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","1.10A","6b6aD-3v39A:16.9","6b6aB-3v39A:11.89"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"SER A  70;SER A 251;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.33A","6b6cA-3v39A:16.9","6b6aD-3v39A:11.89"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","0.65A","6b6dA-3v39A:16.8","6b6cA-3v39A:11.89"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",7,"SER A  70;ILE A 157;SER A 251;THR A 342;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);None;TAU A 501 (-2.6A);None;TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","1.28A","6b6eA-3v39A:16.8","6b6dA-3v39A:11.89"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",6,"SER A  70;ILE A 157;SER A 251;LYS A 357;THR A 358;GLY A 359","TAU A 501 (-1.5A);None;TAU A 501 (-2.6A);TAU A 501 ( 4.3A);None;TAU A 501 (-3.5A)","1.26A","6b6fA-3v39A:16.7","6b6eA-3v39A:11.89"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","3v39","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Bdellovibrio bacteriovorus",5,"SER A 251;ASN A 253;THR A 342;LYS A 357;GLY A 359","TAU A 501 (-2.6A);TAU A 501 (-3.1A);None;TAU A 501 ( 4.3A);TAU A 501 (-3.5A)","0.27A","6c79A-3v39A:17.5","6b6fA-3v39A:11.89"],["6DCH_A_ACTA401_0","SCOE PROTEIN","1gy9","ALPHA-KETOGLUTARATE-DEPENDENT TAURINE DIOXYGENASE","Escherichia coli",4,"HIS A  99;ASP A 101;HIS A 255;ARG A 270"," FE A 300 (-3.4A); FE A 300 (-2.3A); FE A 300 ( 3.3A);TAU A 350 ( 2.9A)","0.37A","6dchA-1gy9A:29.7","6c79A-3v39A:12.89"],["6H7J_A_5FWA401_0","BETA-1 ADRENERGIC RECEPTOR","1gy9","ALPHA-KETOGLUTARATE-DEPENDENT TAURINE DIOXYGENASE","Escherichia coli",5,"TRP A 248;ASP A 101;VAL A 102;PHE A 159;ASN A  95","None; FE A 300 (-2.3A);TAU A 350 (-3.8A);TAU A 350 (-4.3A);AKG A 351 ( 3.5A)","1.22A","6h7jA-1gy9A:undetectable","6dchA-1gy9A:27.33"],["6H7M_A_68HA504_0","BETA-1 ADRENERGIC RECEPTOR","1gy9","ALPHA-KETOGLUTARATE-DEPENDENT TAURINE DIOXYGENASE","Escherichia coli",5,"TRP A 248;ASP A 101;VAL A 102;PHE A 159;ASN A  95","None; FE A 300 (-2.3A);TAU A 350 (-3.8A);TAU A 350 (-4.3A);AKG A 351 ( 3.5A)","1.20A","6h7mA-1gy9A:undetectable","6h7jA-1gy9A:17.21"],["6H7M_B_68HB405_0","BETA-1 ADRENERGIC RECEPTOR","1gy9","ALPHA-KETOGLUTARATE-DEPENDENT TAURINE DIOXYGENASE","Escherichia coli",5,"TRP A 248;ASP A 101;VAL A 102;PHE A 159;ASN A  95","None; FE A 300 (-2.3A);TAU A 350 (-3.8A);TAU A 350 (-4.3A);AKG A 351 ( 3.5A)","1.20A","6h7mB-1gy9A:undetectable","6h7mA-1gy9A:17.21"]]